Calmodulin antagonists inhibit aggregation of human, guinea pig and rabbit platelets induced with platelet activating factor
- 18 April 1983
- journal article
- Published by Wiley in FEBS Letters
- Vol. 154 (2) , 262-264
- https://doi.org/10.1016/0014-5793(83)80161-6
Abstract
Three calmodulin (CM) antagonists W-7, W-5, and trifluoperazine (TFP) were tested for ability to prevent aggregation of human, guinea pig, and rabbit platelets induced by 7.88 μM PAF. The naphthalene sulfonamide derivatives, W-7 and W-5, were active in all species, W-5 being 1,5–5.7-times less potent than W-7, in accordance with W-5 being a weaker CM inhibitor. ED 50-Values for TFP were 155, 160 and 255 μM for rabbit, human and guinea pig platelets, respectively. Results are consistent with the notion that some substances antagonizing CM may inhibit PAF aggregation effects. W-7 is most effective on human platelets (ED 50 51.5 μM). High concentrations of TFP required to antagonize PAF-induced aggregation cautions against ascribing its effects solely to an inhibitory effect on CM.Keywords
This publication has 6 references indexed in Scilit:
- Effect of ibuprofen on systolic blood pressure and aortic PGI2 production in spontaneously hypertensive rats (SHR)Biochemical and Biophysical Research Communications, 1982
- Interaction of drugs with calmodulinBiochemical Pharmacology, 1982
- Human platelet activation by an alkylacetyl analogue of phosphatidylcholineBiochimica et Biophysica Acta (BBA) - General Subjects, 1982
- Biopharmacological Assessment of Calmodulin Function: Utility of Calmodulin AntagonistsPublished by Springer Nature ,1982
- Involvement of calmodulin in platelet reactionThrombosis Research, 1981
- BACKGROUND AND PRESENT STATUS OF RESEARCH ON PLATELET‐ACTIVATING FACTOR (PAF‐ACETHER)Annals of the New York Academy of Sciences, 1981